Dr. Mark J. Phelan, MD

Dr. Phelan practices at Abilene Cataract and Refractive Surgery Center in Abilene, Texas.

Dr. Phelan's NPI, 1801882030, was assigned on September 22, 2005. Dr. Phelan graduated from University of Michigan Medical School in 1990. Dr. Phelan's Michigan license number on file is F79809.

Dr. Phelan's primary practice is Abilene Cataract and Refractive Surgery Center, at 2120 Antilley Rd, Abilene, TX 79606. The practice phone is (325) 695-2020.

Dr. Phelan's primary practice is Abilene Cataract and Refractive Surgery Center in Abilene, Texas. Dr. Phelan is also affiliated with Eastland Memorial Hospital. Dmand AI also links Dr. Phelan to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Phelan practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Phelan's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Phelan is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Phelan's licenses on file in 2 states: Michigan and Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Phelan treats.

CMS data shows 3,708 Medicare services from Dr. Phelan across 12 procedure codes in 2024, for 1,468 Medicare patients. Medicare paid $429,719 for them.

CMS counts 1,468 Medicare patients who saw Dr. Phelan in 2024. The largest group is 65 to 74, with 694 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Phelan's median patient age at 73, with 56% women.

In 2024, Dr. Phelan wrote 3,403 Medicare Part D claims for 1,132 patients. 71% of them were for generic drugs. CMS names the drug for 3,302 of them, across 21 drugs with 11 or more claims each, at $198,662 in total drug cost. In 2023, CMS named 3,324 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Phelan for performance year 2024, reported as part of a group. Dr. Phelan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,013 procedures of cataract surgery by Dr. Phelan, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 10 papers to Dr. Phelan, published from 2010 to 2011. 2011 was the busiest year, with 2. The most frequent topics are Rheumatic Diseases, Antirheumatic Agents and Corneal Diseases. Dr. Phelan has published most often in J Clin Rheumatol.

CMS Open Payments shows 149 general payments to Dr. Phelan from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Carl Zeiss Meditec USA, Inc. paid the most, $2,454.

Dmand AI lists 2 awards for Dr. Phelan.

Dr. Phelan graduated from University of Michigan Medical School in 1990. Dr. Phelan is a member of AAO and ACS.

Dr. Phelan is in network with 21 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.